Rs 150 per dose is not sustainable in long run: Bharat Biotech on Centre's Covaxin price
Hyderabad-based vaccine maker Bharat Biotech on Tuesday said the current supply price of its Covid-19 vaccine Covaxin to the Centre is not sustainable in the long run.
/connect-gujarat-english/media/post_banners/426e0fc616df4a1926031aaa9284a1494f1304365c1e0b5d8d6011b1ef44cd51.webp)
/connect-gujarat-english/media/post_banners/fa0663db3a6a18f8d63973a1663afee0f2e08160a807e07531a0d4ee6f24a9eb.webp)
/connect-gujarat-english/media/post_banners/wp-content/uploads/2021/05/8-17.jpg)
/connect-gujarat-english/media/post_banners/wp-content/uploads/2021/05/4.jpg)
/connect-gujarat-english/media/post_banners/wp-content/uploads/2021/04/2-10.jpg)
/connect-gujarat-english/media/post_banners/wp-content/uploads/2021/04/9-13.jpg)